- AWS and Bluesight build AI for hospital 340B compliance
- AI agent crawlers now need permission. Here’s how to get it
- How to shrink the token budget without shrinking the team
- AWS GraphRAG deployment cuts drug research cycles by 87%
- NHS AI blood test could reduce invasive womb cancer checks
- Insilico Medicine advances AI drug for IPF to Phase III trials
- Companies traded people for tokens. The returns haven’t shown up
- L’Oreal, Mondelez, and Nestle use AI to speed product development
- China’s AI companion rules: what Beijing is really going after
- Takeda signs US$600M AI drug discovery deal with Insilico
- NVIDIA BioNeMo accelerates Anthropic Claude Science
- Deploying retail AI to scale personalisation and customer insight
- Japan’s answer to its worker shortage: An AI model for 10 million robots
- Bank of England reviews AI rules for agentic AI in finance
- Anthropic deploys Claude Sonnet 5, Fable and Mythos restored
